A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection
COVID-19, is a disease resulting from the SARS-CoV-2 global pandemic. Due to the current global emergency and the length of time required to develop specific antiviral agent(s) and a vaccine for SARS-CoV-2, the world health organization (WHO) adopted the strategy of repurposing existing medications...
| Autors principals: | , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://repository.londonmet.ac.uk/5876/1/Abo-zeid%20et%20al%20accepted%20version.docx |